EClinicalMedicine

Structural and functional problems in multiple organs linked to long COVID in a population study

Updated

Abstract

Multi-system impacts of long COVID remain unknown.

  • Comparative analysis was conducted between individuals with long COVID and control subjects.
  • The study focused on identifying deficits across multiple body systems.
  • Findings may reveal differences in health status between the two groups.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

This work is independent research jointly funded by the National Institute for Health and Care Research (NIHR) and UK Research and Innovation (UKRI) “Characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19: providing the evidence base for health care services (CONVALESCENCE), COV-LT-009”. The views expressed in this publication are those of the author(s) and not necessarily those of NIHR, The Department of Health and Social Care or UKRI. AH and NC receive support from the British Heart Foundation, the National Institute for Health Research University College London Hospitals Biomedical Research Centre and the UK Medical Research Council. NC receives funds from AstraZeneca to participate in Data Safety and Monitoring Committees for clinical trials. AH additionally receives funds from the Wellcome Trust, Horizon 2020 and Horizon Europe Programmes of the European Union. MNL also received support from NIHR, the Chronic Disease Research Foundation, King’s Population Health Institute and King’s College London Climate and Sustainability Seed Fund, received a speaker fee from Nestle Ltd and holds a leadership or fiduciary role in the Irish Elderly Advice Network charity, the British Geriatric Society Research and Development Committee, the South London NIHR Research Delivery Network and the Vivensa Academy. BR received funding support from the NIHR Oxford Biomedical Research Centre Doctoral Fellowship, a British Heart Foundation Centre of Research Excellence Intermediate Clinical Transition Fellowship (RE/18/3/34214), a Wellcome Trust Career Development Award and received consulting fees from Imbria Pharmaceuticals. CS receives support from NIHR UCL Biomedical Research Centre and the BHF, and she participates on an Advisory Board for MONAI and Brain Key. DW receives support from Alzheimer’s Research UK, University College London Hospital Biomedical Research Centre and Alzheimer’s Society (UK). The BCCP received infrastructure support from the British Heart Foundation and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. Alex Whitmarsh could not be contacted his disclosures are not known. No other authors declare interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free